http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5596018-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
filingDate 1993-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1997-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ef7e2929c2aeb9beff23774df3c5930
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44ec6450b6f4e0490bbbad03ed8a9c62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23015874921693b814661be32f6c9ce1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_574aab798708ebc7576bea67218f022a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b96cb287a5b88416677e0d8cb628e35e
publicationDate 1997-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5596018-A
titleOfInvention Antiviral agents against aids-causing virus
abstract An antiviral agent against viruses causative of AIDS, containing fuchsinic acid as an active ingredient. n The antiviral agents provided by the present invention inhibit cellular infection by AIDS-causing virus and progress of the infection into ARC and are effective in the treatment of AIDS.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7462605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6683061-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7601703-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7605144-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7419968-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009069268-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004077588-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003109697-A1
priorityDate 1988-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S54117025-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4277492-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127850182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127960603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395421
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44630569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128610196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398513

Total number of triples: 40.